top of page
Crystal-Geode-Cross-section_edited.jpg

Medical Weight Loss Program in Alexandria, VA
 

Provider-supervised weight loss with GLP-1 therapy (Semaglutide, Tirzepatide, Oral Wegovy and Rybelsus), Phentermine, and prescription medications. Board-certified nurse practitioner serving Alexandria, Arlington, Springfield, Lorton, and Northern Virginia.

Why Is Obesity So Difficult to control?
 Obesity is a complex, chronic medical condition influenced by biological, psychological, environmental, and genetic factors. It is not a matter of willpower or personal weakness—it's the result of how the body regulates hunger, hormones, energy use, and metabolism over time.

Prescription Weight Loss Medications - Alexandria VA
FDA-approved medications prescribed by our board-certified nurse practitioner

GLP-1 AGONIST

Rybelsus/Wegovy (Oral)

 

Daily oral medication for appetite control without injections. Most popular in Alexandria VA.

 

—5-15% body weight reduction —No injections required

—Long-term management

APPETITE SUPPRESSANT

Phentermine 

 

Proven appetite suppressant for jump-starting weight loss with medical supervision.

 

 

—Boosts energy & metabolism —Reduces hunger, long acting

—Short-term use (6-8 months)

COMBINATION

Contrave

 

Dual-action formula for emotional and reward-driven eating patterns.

 

 

—Addresses cravings

—5-10% weight loss

—Gradual dose escalation

INSULIN SENSITIZER

Metformin 

 

Improves insulin sensitivity for patients with metabolic concerns or prediabetes.

 

—Supports metabolic health

—Aids appetite regulation

—Well-studied safety profile

ANTI-CRAVING

Topiramate 

 

Reduces binge eating behaviors and impulse cravings in combination protocols.

 

 

—Binge eating reduction

—Impulse control

—Careful titration

APPETITE CONTROL

Phendimetrazine

 

Alternative appetite suppressant for moderate obesity management.

 

 

 

—Promotes fullness

—Medical supervision

—Alternative to phentermine

—Take 30 min before meal

DUAL GIP/GLP-1 AGONIST

Tirzepatide (Zepbound)

Dual-action injectable targeting both GIP/GLP-1 receptors for enhanced appetite control and blood sugar regulation.

 

—20-25% weight reduction 

—Weekly injection

—Superior to semaglutide 

—Addresses insulin resistance

Frequently asked questions

bottom of page